Tectonic Therapeutic
$30.75
35
+$0.83+2.77% Friday 20:00
+$0.00+0%Friday 20:00After hours
Statistics
Day High
30.92
Day Low
30.75
52W High
39.53
52W Low
14.39
Volume
5,745
Avg. Volume
-
Mkt Cap
601.14M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.39
-1.2
-1.02
-0.84
Expected EPS
-1.321367
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-74.15MNet Income
Analyst Ratings
83.00Average Price Target
The highest estimate is 93.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TECX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Regenxbio
RGNX
Mkt Cap637.69M
Pfizer
PFE
Mkt Cap159.36B
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Novartis
NVS
Mkt Cap292.35B
About
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Show more...
CEO
Alise S. Reicin
Employees
60
Country
United States
ISIN
US8789721086
Listings
0 Comments
Share your thoughts
FAQ
What is Tectonic Therapeutic stock price today?▼
The current price of TECX is $30.75 USD — it has increased by +2.77% in the past 24 hours. Watch Tectonic Therapeutic stock price performance more closely on the chart.
What is Tectonic Therapeutic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tectonic Therapeutic stocks are traded under the ticker TECX.
Is Tectonic Therapeutic stock price growing?▼
TECX stock has fallen by -13.67% compared to the previous week, the month change is a +4.03% rise, over the last year Tectonic Therapeutic has showed a +83.04% increase.
What is Tectonic Therapeutic market cap?▼
Today Tectonic Therapeutic has the market capitalization of 601.14M
When is the next Tectonic Therapeutic earnings date?▼
Tectonic Therapeutic is going to release the next earnings report on November 05, 2026.
What were Tectonic Therapeutic earnings last quarter?▼
TECX earnings for the last quarter are -1.18 USD per share, whereas the estimation was -1.35 USD resulting in a +12.51% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tectonic Therapeutic revenue for the last year?▼
Tectonic Therapeutic revenue for the last year amounts to 0 USD.
What is Tectonic Therapeutic net income for the last year?▼
TECX net income for the last year is -74.15M USD.
How many employees does Tectonic Therapeutic have?▼
As of September 05, 2026, the company has 60 employees.
In which sector is Tectonic Therapeutic located?▼
Tectonic Therapeutic operates in the Health & Wellness sector.
When did Tectonic Therapeutic complete a stock split?▼
The last stock split for Tectonic Therapeutic was on June 21, 2024 with a ratio of 1:12.
Where is Tectonic Therapeutic headquartered?▼
Tectonic Therapeutic is headquartered in WATERTOWN, United States.